Is stem cell therapy for Muscular Dystrophy worth it?
Outside an authorised, subtype-specific protocol, current evidence does not justify paying for an unidentified MSC or exosome product as muscular-dystrophy treatment. Independent specialist review should compare approved options, supportive care, trial eligibility and total burden.
How stem cells are studied for Muscular Dystrophy
Muscular dystrophies are a diverse group of inherited disorders, so diagnosis, affected gene, age, cardiac and respiratory status and disease stage determine appropriate care. Research spans gene replacement, exon skipping, gene editing, muscle progenitors and supportive-cell strategies. These mechanisms are different, and an MSC infusion does not correct an underlying pathogenic variant or reproduce an approved gene-targeted product.
Am I a candidate? → · Muscular Dystrophy: full overview → · Muscular Dystrophy cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.